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Abstract
Hypoglycemia occurs in approximately 8-30% of neonates born to mothers with diabetes.
The full extent of the individual and contextual risk factors of hypoglycemia remains unclear
and no systematic review of the available studies exists to date. We identified published
studies using PubMed and EBSCO host search engines. A modified STROBE statement was
used to assess studies’ strengths, weaknesses, and generalizability. A total of 16 articles were
eligible for full text review. The clinical risk factors in these studies were broadly classified
into two: infant-related and mother-related risk factors. The identified infant-related risk
factors were SGA, macrosomia, prematurity, lower cord blood glucose, ponderal index and
male sex. On the other hand, mother-related risk factors includes maternal hyperglycemia,
ethnic origin, diabetes diagnosed prior to 28 weeks of gestation, pre-pregnancy BMI of
≥ 25 kg/m2, blood glucose, maternal diabetes type and maternal HbA1c. Irrespective of
diabetes type, infants born to diabetic mothers appear to have a higher risk of developing
hypoglycemia compare to those born to normal mothers. The overall evidence suggested
that these studies mainly focus on the clinical characteristics of infants and mothers. Future
research should focus on the identification of risk factors at the individual and contextual
levels that can independently predict neonatal hypoglycemia. Appropriate emphasis should
also be given to better define neonatal hypoglycemia.
Keywords: Neonatal hypoglycemia, Diabetic mothers, Birth complications, Risk factors.
Accepted November 30, 2016

Background
Neonatal hypoglycemia is a common metabolic
abnormality in newborns due to inability to maintain
glucose homeostasis [1,2]. Glucose is an essential primary
substrate for the brain and its consumption by the brain is
high and as a result, neurons and glial cells are susceptible
to hypoglycemia [3,4]. Therefore, glucose homeostasis is
crucial for the overall physical development of newborns
[5]. Throughout gestation, maternal glucose provides all
the glucose for the fetus via facilitated diffusion across
the placenta according to a maternal-to-fetal glucose
concentration gradient [5]. Hypoglycemia was defined
by studies as early as 1937 as “mild” (2.2–3.3 mmol/l),
“moderate” (1.1–2.2 mmol/l), and “severe” (<1.1
mmol/l) [6]. A specific blood glucose concentration to
define neonatal hypoglycemia for infants is a subject of
controversy [7-10]. However, it is generally accepted that
neonatal hypoglycemia is defined by a plasma glucose
level of less than 30 mg/dl or 1.65 mmol/l in the first 24
h of life [11]. To date, hypoglycemia remains one of the
major metabolic abnormalities of the newborn [12-14].
The most common symptoms of neonatal hypoglycemia
42

are shakiness, tachycardia, lethargy, and temperature
irregularities [15,16]. In the presence of these symptoms,
neonatal hypoglycemia is defined as capillary plasma
glucose of less than 46 mg/dl (2.6 mmol/l) [15]. Prolonged
neonatal hypoglycemia may also cause neuroglycopenic
signs such as seizure, coma, cyanotic episodes, apnea,
bradycardia or respiratory distress and hypothermia [4,17].
Several clinical conditions could be associated with
neonatal stress that could affect glucose homeostasis of the
newborn infant including infection, asphyxia, congenital
heart disease, decreased substrate availability as a result
of birth defects, prematurity and fetal growth restriction,
islet cell hyperplasia, erythroblastosis fetalis, and
Beckwith-Wiedemann Syndrome [4,18-22]. In addition,
endocrine abnormalities such as pan-hypopituitarism,
hypothyroidism, adrenal insufficiency, increased glucose
utilization, sepsis and perinatal asphyxia could also be
associated with neonatal hypoglycemia [17,18]. Although
in most of these neonates, hypoglycemia is transient and
asymptomatic, unrecognized hypoglycemia may lead to
neonatal seizures, coma, and neurologic injury [15,23-26].
The risk of developing hypoglycemia among infants
Curr Pediatr Res 2017 Volume 21 Issue 1
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born from diabetic mothers is even higher [27-34].
Hypoglycemia occurs in approximately 8-30% of neonates
born to mothers with diabetes, with an estimated incidence
rate of approximately 27% among infants born to women
with diabetes compared to 3% among apparently healthy
full-term infants born to non-diabetic women [35-38].
Although the predisposing risk factors for the development
of neonatal hypoglycemia in diabetic pregnancies are
thought to be mainly related to poor maternal glycemic
control, neonatal weight at birth, and gestational age at
delivery, the full extent of the individual and contextual
risk factors remains unclear. In addition, to date, no
systematic reviews of the available studies exist [39,40].
Our objective is to conduct a systematic review of the
literature on the risk factors for hypoglycemia in infants
of diabetic mothers. Accordingly, all relevant empirical
studies on neonatal hypoglycemia in diabetic mothers
were reviewed and appraised for methodological quality.
The results were summarized in a way that informs both
clinical practice and future research.

Method
Search Strategy
We identified published studies using PubMed and
EBSCOhost search engines. The search was carried out by
using the population, intervention, control, and outcome
(PICO) strategy. The following concepts and related key
words searched in their respective PICO category and
they were finally combined together: (1) neonatal terms
(‘neonate, ‘neonates’, ‘neonatal’, ‘newborn’, ‘newborns’
and ‘infant’), (2) diabetes and pregnancies terms
(‘pregnancy in diabetics’, ‘diabetic mothers’, ‘diabetic
pregnancy’, ‘pregnancy in diabetes’) and outcome terms
(‘hypoglycemia’, ‘hypoglycaemia’, ‘hypoglycemic’ and
‘neonatal hypoglycemia’). We included all empirical
studies published in the English language between
January 1, 2000 and March 31, 2016. Additional studies
were identified from reference lists of identified articles.
The following inclusion and exclusion criteria were used
to identify relevant articles:
Inclusion Criteria
(1)
Observational studies, (2) neonatal hypoglycemia
is used as the primary outcome of interest, (3) neonates
born from type 1 (defined as blood glucose ≥ 11.1
mmol/l), type 2 (defined as fasting blood glucose ≥ 7.0
mmol/l or ≥ 11.1 mmol/l during OGTT) or gestational
diabetic mothers (defined as having at least two plasma
glucose measurements during the diagnostic test of the
following OGTT glucose threshold values: 5.3 mmol/l
fasting, 10.0 mmol/l at 1 h, 8.7 mmol/l at 2 h and 7.8
mmol/l at 3 h), (4) has appropriate comparison group, (5)
neonatal hypoglycemia diagnosed within 3 days of life,
and outcome defined in the ranges of 20 to 50 mg/dl or
1.1-2.8 mmol/l.
Exclusion Criteria
(1) Animal studies, (2) review articles, (3) articles
published in non-English language, (4) articles
Curr Pediatr Res 2017 Volume 21 Issue 1

published prior to 2000, and (5) poorly defined
comparison group.
Data Abstraction and Overall Assessment of Studies
The abstracts of all potential publications were reviewed
initially by the first (B.A.) and the second (O.O.) authors
to identify eligible publications for further review. Full
text screening was made by the two authors through
detailed review of the complete text of each article using
the inclusion/exclusion criteria as a guideline. The two
authors then independently reviewed publications that
were identified for inclusion. Relevant study attributes
were extracted from the selected publications using
standardized forms developed for the systematic review
project by the authors. A third author (M.A) mediated to
resolve any disagreements between the authors.
The STROBE (Strengthening the Reports of Observational
Studies in Epidemiology) Statement (checklist of items
that should be included in reports of observational studies)
was used to assess studies’ strengths, weaknesses, and
generalizability. An explanation and elaboration article that
discusses each checklist item and gives methodological
background and published examples of transparent
reporting were used in conjunction with the STROBE
checklist [41]. As most of the studies in this topic are
observational, we used the STROBE checklist as a guide
to systematically evaluate the studies that were included in
this review. The STROBE checklist has 21 items with 15
items relevant to all three study designs (i.e., cohort, casecontrol, and cross-sectional studies) and 4 are specific for
each. However, items 1-3 (background and objectives),
6b (for matched studies), 11 (quantitative variables) and
22 (funding information) were removed as they were not
applicable to the included studies. Therefore, a modified
15-item STROBE checklist was used to critically appraise
study quality for this systematic review.

Results
Study Selection
A total of 1233 titles were identified on PubMed and
EBSCOhost in the initial literature search, 1202 of which
were excluded by the first screening based on the title or
abstract, leaving 31 articles for full-text review (Figure
1). Thirteen of these studies met the inclusion criteria and
an additional 3 articles were included from references
listed these articles, resulting in 16 eligible studies, most
of which were based on observational studies (Table 1)
[27,35,41]. The main reasons for excluding studies after
full review were (i) hypoglycemia was not listed as primary
outcome, (ii) comparison group were not defined and, (iii)
hypoglycemia was not defined within the specified range
of 1.7-2.8 mmol/l.
We identified four prospective cohorts, one nested casecontrol and ten retrospective cohort studies that examined
the various clinical risk factors for hypoglycemia in
diabetic mothers. Mother’s diabetes types included
Gestational Diabetes Mellitus (GDM), Type-1 Diabetes
Mellitus (T1D) and type-2 diabetes mellitus (T2D). Other
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Table 1. Description of included neonatal hypoglycemia studies
Glucose
Mother’s Definition of Measurement
Author(s)
Patients Clinical
Design, N
Location
Diabetes Hypoglycemia, Method
(Year)
Characteristics
Type
mmol/l/mg/dl (infant,
mother)
38 term infants of
well-controlled
diabetic, 37 wk
Agrawal et
gestation, 5 preHexokinase;
Prospective
GDM
<2/36
al. (2000)
Australia
existing diabetes,
QIDTM
cohort, 38
[22]
35 GDM, 16
managed on
insulin, 17 on diet
139 GDM (76.7%
Majeed et
NS, BioRad
Prospective
diet control,
GDM
al. (2011)
Malaysia
≤ 2.6/47
D-10
Cohort, 150
23.3% insulin), 11
[44]
pre-existing
302 singleton,
asymmetric
LGA (63),
Bollepalli
Retrospective
symmetric LGA
NS; Ames
et al. (2010)
U.S.
T1D
<1.1/20
Cohort, 229
(67), asymmetric
Dextrometer
[56]
non-LGA (30),
symmetric nonLGA (142)
1560 infants
Ferrara et Nested Case–
with neonatal
NS;
al. (2007) Control,
U.S.
complications,
GDM
<2.2/40
Hexokinase
[55]
2444
884 control
infants
2029 NH infants
Garciaand 63 non-NH
Patterson et Retrospective
infants; 2029
Cornblath
Spain
GDM
<2.22
al. (2012) Cohort, 2092
pregnancies
criteria; NS
[57]
of women with
GDM
305 singleton
Das et al. Retrospective
neonates with a
GDM
<2.8/50
NS
U.S.
(2009) [58] cohort, 305
birth weight of
4000 g
(>2.6/47), Mild
576 term infants,
(2.2/40-2.5/45),
Metzger et
37–42 week
GDM-A1,
Retrospective
Moderate
Glucometer
al. (2014)
Israel
gestation, nonGDM-A2,
cohort, 576
(1.7/31Elite XL; NS
[35]
complicated
IDDM
2.1/38), Severe
vaginal delivery
(<1.7/31)
Mitrovic et
94 mothers with
Retrospective
GDM;
al. (2014)
Serbia
GDM, 48 T1D, 14
NS
NS
cohort, 156
T1D
[59]
T2D; 106 controls
Persson et Prospective
3517 singletons,
al. (2012) cohort study, Sweden 32–43 week
T1D
<2.6/47
NS
[43]
3517
gestation
Singleton
pregnancies
Sure Step
Ramos et al. Retrospective
diagnosed with
GDM;
Flexx Glucose
U.S.
<2.5/45
(2012) [15] Cohort, 385
GDM b/n 12 and T2D
Meter; NS
34 week (191),
T2D (51)
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Outcome
Measured Risk
(hour
Factors
after
Assessed
birth)

0.5, 1, 2

UBCG,
RDS,
BW

3

HbA1c

NS

HB; AC,
RD, PC

NS

MS, HB

48

GA,
CBG,
HbA1c,
IT, BMI,
WDP,
MP, NG

NS

RDS; BI;
CH, HS,

1, 2, 4,
6, 8

NS
6

0.5

AGA,
SGA,
LGA,
CD, MA,
MH,
MSAF
AS; BW,
GA,CD,
PE
AS; BT,
ARD;
HB
PI; GA,
CD, MA,
MOGCT;
CD

Curr Pediatr Res 2017 Volume 21 Issue 1
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Flores-le
Prospective
Roux et al.
Cohort,190
(2012) [27]

Spain

Ryan et al. Retrospective
Canada
(2012) [60] cohort, 274

Sarkar et al. Prospective
(2003) [42] cohort, 160

U.S.

Taylor et al. Retrospective
UK
(2002) [61] Cohort, 107

Normal
(>2.5/45), Mild
(2.2/40-2.4/43), Chromogen
GDM
Moderate
Reagent
(1.6/29Strips; NS
2.1/38), Severe
(<1.6/29)
Capillary
55 T1D, 55 T2D, GDM,
<2/26
Blood
164 GDM
T1D, T2D
Glucose; NS

190 infants,
39.3 week mean
gestational age;
3349 mean birth
weight

PBMI;
IG; GA;
IL; CD;
1, 2, 4, 8,
BW;
12, 18, 24
LGA;
AC;
UCPH
Hourly

MBG

Infants born at 2
36 wk to women
with GDM
(class Al) over
a period of 16
months; Infants
born at 2 36 wk
to nondiabetic
women

GDM-A1 <2.2/40

glucose
oxidase; NS

0.5-1, 3

BW, GA,
AC, MC,
HbA1c

12.9 years of
average duration
of Type-1
Diabetes; 44
primigravidas

T1D

Yellow
Springs

NS

MC

<2.5/45

PB, AS,
LGA,
Tundidor et Retrospective
SGA, OT,
al. (2012) Cohort, 2299 Spain
<2.6/47
NS
NS
JD, CM,
[62]
RDS, PT,
HC, PM
MI,
39 week average
TDM,
Gestation; 3300
Automated
VanHaltren Retrospective
GDM,
HbA1c,
Australia g. average birth
<2.6/47
bench top
0, 4
et al. (2013) Cohort, 326
T1D, T2D
BGL,
weight; 15% LGA
blood gas; NS
GA, PM,
infants
BW
UCBG: Umbilical Cord Blood Glucose; RDS: Respiratory Distress Syndrome; BW: Birth Weight; NS: Not Stated; HbA1c:
Glycated Hemoglobin; HB: Hyperbilirubinemia; AC: Acidosis; PC: Polycythemia; MS: Macrosomia; GA: Gestational Age;
IT: Insulin Treatment; BMI: Body Max Index; WDP: Weight During Pregnancy; MP: Multiple Pregnancy; NG: Newborn
Gender, BI: Birth Injury; CH: Cephalhaematoma, HS: Hospital Stay; CD: Cephalhaematoma; CD: Cesarean Delivery;
MA: Maternal Age; MH: Maternal Hypertension; MSAF: Meconium-Stained Amniotic Fluid; AS: Apgar Score; PE: PreEclampsia; BT: Birth Trauma; ARD: Acute Respiratory Disorders; PI: Ponderal Index; MOGCT: Maternal Oral Glucose
Challenge Test; PBMI: Pregestational BMI: IG: Insulin in Gestation; IL: Insulin in Labor; UCPH: Umbilical Cord Venous
pH; MBG: Maternal Blood Glucose; MC: Microsomia; PT: Polycythemia; HC: Hypocalcaemia; PM: Perinatal Mortality;
CM: Congenital Malformation; OT: Obstetric Trauma; JD: Jaundice; PB: Preterm Birth; MI: Maternal Insulin; TDM: Type of
Gestational Diabetes; PM: Prematurity
Singleton
pregnancies of
women with
GDM
GDM; <22 week
gestation

details on included studies are summarized in Table 1. A
total of 13,248 infants were identified in the 16 included
studies. The key findings are described in the following
section (Table 2).
Critical Appraisal
The two authors agreed initially on 228 out of 250
(95%) items on the modified STROBE checklist. All
disagreements were resolved by discussion among the
two reviewers. Overall, the quality scores of the included
studies ranged from 26.66% to 86.66%, with a median of
46.66%. Included studies were classified as high quality

Curr Pediatr Res 2017 Volume 21 Issue 1

if the individual quality scores were ≥ 80%; studies were
classified as moderate quality for quality scores between
80% and 59% and studies with quality scores below
60% was classified as low quality. Accordingly, a total
of five high quality, two moderate quality and nine low
quality studies were identified [11,16,20,22,28-39]. The
individual item, assessment responses, and quality scores
can be found in Table 3.
Clinical Significance and Risk Factors of Neonatal
Hypoglycemia
Four prospective cohort studies examined various
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1233 studies retrieved in the initial search
• 661 EBSCOhost
• 572 PubMed

I

•

1233 titles and abstracts read

•
•
•
•

•

Animal studies
Review a1ticles
Written in the non-English language
Studies not conducted between 2000 and 2016
Duplicates

I31 full atticles were reviewed
•
•
•
•

l....__l

7 Studies did not include diabetic mothers
4 Hypoglycemia not listed as primary outcome
4 Comparison group not defined
3 Hypoglycemia not defined in 11111101/1or mg/dl

• 3 a1ticles identified in the cited references search

r---1~-----~

IAtotal of 16 atticles met the inclusion criteria and were included for detailed review
Figure 1: Selection process for including studies in the systematic review
risk factors of hypoglycemia in neonates of women
with different diabetes type [22,27,42,43]. Roux et al.
[27] prospectively examined glucose levels in infants
of women with GDM and the influence of maternal,
gestational and peripartum factors on the development
of hypoglycemia. They found that hypoglycemic infants
were more frequently Large for Gestational Age (LGA)
(29.3% vs. 11.3%), had lower umbilical cord pH (7.28
vs. 7.31), and their mothers had more frequently been
hyperglycemic during labor (18.8% vs. 8.5%). The study
obtained data from infants born in a hospital to mothers
with GDM over a period of 30 months. After adjusting for
confounding factors, umbilical cord venous pH [odds ratio
(OR): 0.04, 95% Confidence Interval (CI): 0.261–0.99)]
and Pakistani origin patients (OR: 2.94; 95% CI: 1.14
7.55) were significantly and independently associated with
hypoglycemia. Similarly, Agrawal et al. [22] found that
infants of mothers diagnosed with GDM or preexisting
diabetes prior to 28 weeks gestation were at a higher
risk of developing hypoglycemia compared to those with
maternal diabetes diagnosed at 28 weeks gestation (OR:
7.2, 95% CI: 1.3-40.7). However, there was no difference
in the cord blood glucose levels between infants with or
without hypoglycemia.
Sarkar et al. [42] on the other hand, examined the risk
of developing hypoglycemia in infants born to women
46

with diet-controlled GDM (GDM-A1), insulin-requiring
(GDM-A2) and Insulin-Dependent Diabetes (IDDM) at
36 weeks of gestation compared to infants born to healthy
controls using data obtained over a period of 16 months.
They found that there is no significant difference in the
incidence of hypoglycemia in infants born to GDM-A1
(4.3%) compared to infants born to healthy controls
(4.4%). They concluded that infants born to GDM Class
A1 women at ≥ 36 weeks of gestation are not at increased
risk of developing hypoglycemia. Cordero and Landon
also found a 3% incidence of transient hypoglycemia in
healthy full-term infants born to non-diabetic women
[37,38].
Using national data from the Swedish Medical Birth
Registry, Persson et al. [43] investigated whether
disproportionate body composition is a risk factor for
perinatal complications, including hypoglycemia, in
LGA infants born to mothers with T1D. Their findings
showed that there was no significant difference in the
risk for hypoglycemia between proportionate LGA (OR:
1.42, 95% CI: 1.01-2.0) and disproportionate LGA infants
(OR: 1.42, 95% CI: 0.97-2.08) compared to Appropriate
for Gestational Age (AGA). Disproportionate LGA
was defined as Ponderal Index (PI)>90th centile and
proportionate <90th centile LGA according to gestational
age and sex (Table 2) [44-63] . Similar results were
Curr Pediatr Res 2017 Volume 21 Issue 1
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Table 2. Results of included studies of hypoglycemic neonates born from diabetic mothers
Authors (s). (Years)
Main Results
Hypoglycemia in 18 (47%) infants developed during the first 2 h of life. There was no difference
in the cord blood glucose levels between infants with or without hypoglycemia. Infants of
Agrawal et al.
mothers with diabetes diagnosed prior to 28 weeks gestation were at a higher risk of developing
(2000) [22]
hypoglycemia (OR 7.2, 95% CI: 1.3–40.7). Hypoglycemic infants were of significantly higher
birth weight (3681) compared to normal infants (3160).
There were 16 neonates who were hypoglycemic at delivery. The area under the Receiver Operator
Majeed et al. (2011)
Characteristics (ROC) curve for predicting neonatal hypoglycemia was 0.997 with a 95% CI of
[44]
0.992 to 1. The optimal threshold value for HbA1c in predicting NH was 6.8%.
Asymmetric LGA infants had 3.5 (95% CI: 1.4, 8.7), 2.2 (95% CI: 1.2, 4.2) and 3.2 (95% CI: 1.7,
Bollepalli et al.
5.9) fold greater odds of hypoglycemia, hyperbilirubinemia and composite morbidity, respectively,
(2010) [56]
compared with symmetric non-LGA infants.
A total of 486 with infants with hypoglycemia, 488 with macrosomia, and with hyperbilirubinaemia
Ferrara et al. (2007) were identified. Women with GDM by ADA criteria had an increased risk of having an infant
[55]
with hypoglycemia (OR: 2.61, 95% CI: 0.99–6.92), macrosomia (3.40, 95% CI: 1.55–7.43) or
hyperbilirubinaemia (2.22, 95% CI: 0.98–5.04) compared to healthy control infants.
2
Garcia-Patterson et The rate of hypoglycaemia in neonates was 3% (63). Maternal pre-pregnancy BMI of 25 kg/m
was an independent predictor of hypoglycaemia irrespective of potential intermediate variables being
al. (2012) [57]
included in the model (OR: 2.11, 95% CI: 1.10–4.03) or without (OR: 2.66, 95% CI: 1.44–4.92).
The incidence of hypoglycemia among IDMs was 56.1% compared to non-IDMs 28.6%. There
was significantly more hypoglycemia among the group weighing >4500 g compared to the group
Das et al. (2009)
weighing 4000–4499 g. Compared to IDMs, non-IDMs were born later (40 vs. 38 week), were
[58]
more likely to be delivered vaginally (70% vs. 34%) and had a higher incidence of birth injury
than IDMs (8% vs. 2.4%).
Among the neonates in the study group 29 (36.7%) had at least one hypoglycemia value of <47
Metzger et al. (2014) mg/dl and 8 (10.1%) had a value of <40 mg/dl in the first 8 h of life. After controlling confounding
[35]
factors such as birth weight, delivery number, and grasp evaluation only lower cord blood glucose
significantly predicted hypoglycemia for each decrease of 10 mg/dl (OR 2.11, 95% CI: 1.1–4.03).
The incidence of neonatal hypoglycemia was 52% in mothers with Type 1 diabetes, and 16.5% in
mothers with Type 2 diabetes or GDM. The incidence neonatal morbidities such as hypoglycemia,
Mitroviu et al.
pathological jaundice, and other neonatal pathologies at birth, was statistically significantly higher
(2014) [59]
and Apgar scores after 1 min and after 5 min were statistically significantly lower in the mothers
with diabetes (type 1 and 2) compared to the healthy women.
Neonatal morbidities were significantly more frequent in LGA compared to AGA infants. The
proportions of preterm births and girls were significantly higher in LGA infants (44% preterm and
Persson et al. (2012)
52% girls) compared with AGA infants (30% preterm and 47% girls) born to women with Type
[43]
1 diabetes. The risks of hypoglycemia were comparable between P-LGA and D-LGA infants. No
significant difference in risk was found between AGA and P-LGA and D-LAG.
The incidence of hypoglycaemia was 18% (44/242). The incidence was significantly higher in
those requiring pharmacotherapy (25% vs. 3%). The frequency of hypoglycaemia between the
Ramos et al. (2010)
glyburide and insulin-treated pregnancies did not differ significantly (23% vs. 27%). The frequency
[15]
of hypoglycaemia was statistically associated with birth weight, macrosomia and ponderal index.
Ponderal index was the strongest predictor of hypoglycaemia (OR: 5.59, 95% CI: 1.34–23.25).
A total of 23 (12.1%) mild, 20 (10.5%) moderate and 5 (2.6%) severe hypoglycemia were observed.
Hypoglycemic infants were more frequently LGA (29.3% vs. 11.3%) had lower umbilical cord pH
Flores-le Roux et al. (7.28 vs. 7.31) and their mothers had more frequently been hyperglycemic during labor (18.8%
(2012) [27]
vs. 8.5%). Pakistani origin (OR: 2.94; 95% CI: 1.14 7.55) and umbilical cord venous pH (OR:
0.04, 95% CI: 0.261–0.99) were significantly and independently associated with hypoglycemia in
multivariate analysis.
The NH rate was 7.3% (4.9% in GDM mothers and 10.9% of mothers with pre-existing diabetes).
The insulin-glucose infusion was used in 47% of women with T1D, T2D, and GDM requiring
≥ 0.5 units/kg/day of insulin during pregnancy and in 8% of women with GDM treated by diet
Ryan et al. (2012) or <0.5 units/kg/day of insulin. The overall rate of maternal hypoglycaemia was low (6.6% with
[60]
blood glucose ≤ 3.5 mmol/L and 1.5% ≤ 3.0 mmol/L) pre-delivery; 13.9% of women had a blood
glucose level ≥ 7.0 mmol/L. Standardized management for diabetic women in labour using an
intravenous insulin-glucose protocol was effective in achieving stable maternal blood glucose
levels with low rates of neonatal hypoglycaemia.

Curr Pediatr Res 2017 Volume 21 Issue 1
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The incidence of hypoglycemia was 4.3% in the GMD-A1 group compared to the control, 4.4%.
Neonatal morbidity in infants born to GDM-A1 women is similar to that seen in infants of nondiabetic women. Unlike infants of insulin-dependent diabetic and insulin requiring GDM women,
Sarkar et al. (2003)
infants born to GDM-A1 women at 36 weeks of gestation or more were not at increased risk of
[42]
developing hypoglycemia, hypocalcemia, hypomagnesemia, polycythemia, hyperbilirubinemia,
birth trauma or birth asphyxia. Infants born at 36 weeks or more gestation to class A1 GDM
women can be managed like any other normal full-term infant born to a non-diabetic woman.
Hypoglycemia correlates with maternal hyperglycemia in labor, not with HbA1c during pregnancy.
Taylor et al. (2002) Blood glucose was less than 2.5 mmol/l in 50 neonates and was less than 2.0 mmol/l in 18 neonates.
[61]
Maternal blood glucose control in pregnancy had no bearing on the incidence of NH, but maternal
blood glucose during labor influenced neonatal blood glucose if over 8 mmol/l.
Male sex was an independent predictor of neonatal hypoglycemia (OR 2.13) and CS (OR 1.48).
As to neonatal hypoglycaemia, intravenous glucose was required in 16.7% of infants (7.4% in
Tundidor et al.
female vs. 24.2% in male fetuses; NS). The increased risk of neonatal hypoglycemia in male
(2012) [62]
fetuses of mothers with GDM is also the most relevant result in terms of clinical practice, advising
an increased awareness of neonatal hypoglycemia in these new-borns.
Hypoglycaemic episodes occurred in 109 (33.4%) infants. Macrosomia was present in 15% of
VanHaltren et al.
the infants. Maternal diabetes Type, HbA1c, prematurity, macrosomia and temperature instability
(2013)
were identified as risk factors for neonatal hypoglycaemic.
obtained by Leperque et al. [64] while Ballard et al. [65]
and Bollepalli et al. [56] contrasted the result. In a nested
case-control study, Ferrara et al. [29] found that women
with GDM defined by American Diabetes Association
(ADA) criteria had an increased risk of having an infant
with hypoglycemia (OR: 2.61, 95% CI: 0.99–6.92),
although not statistically significant. The study used
a group practice database that included 16 hospitals
and provides medical services to approximately 3.0
million people. Their findings supported the ADA 2000
recommendations (GDM, 2000) to adopt lower plasma
glucose thresholds proposed by Carpenter and Coustan
for the diagnosis of GDM [42].
We also identified ten retrospective cohort studies and
one nested case-control study that examined the risk of
developing hypoglycemia in infants born to mothers
with different diabetic conditions [15,35,56-63]. Most of
these observational studies were conducted using medical
institution based databases.
Garcia-Patterson et al. [57] examined the relationship
between maternal pre-pregnancy BMI and hypoglycemia
among infants born to women with GDM with a gestational
age higher than 22 weeks using databases from a tertiary
care center. Maternal pre-pregnancy BMI ≥ 25 kg/m2 was
determined as an independent predictor of hypoglycemia
irrespective of potential intermediate variables being
included in the model (OR: 2.11, 95% CI: 1.10–4.03)
or without (OR: 2.66, 95% CI: 1.44–4.92). The rate of
hypoglycemia in neonates was 3% (63). On the other
hand, Metzger et al. [35] examined the impact of duration
of delivery room breastfeeding on blood glucose levels
(BGL) during the first hours of life among term neonates
born to mothers with GDM and to examine its relationship
with hypoglycemia using a medical center database.
Among the neonates in the study group, 29 (36.7%) had at
least one hypoglycemia value of <47 mg/dl and 8 (10.1%)
had a value of <40 mg/dl in the first 8 h of life. After
controlling confounding factors such as birth weight,
delivery number and grasp evaluation only lower cord
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blood glucose significantly predicted hypoglycemia for
each decrease of 10 mg/dl (OR 2.11, 95% CI: 1.1–4.03).
The mean glucose at the first hour of life was 56.2 mg/dl
(range 28–105 mg/dl). A trend towards a higher incidence
of normoglycaemia (>40 mg/dl) was recorded for the longer
duration of delivery room breastfeeding subgroup (OR:
1.923 95% CI: 0.984-3.76) [66]. However, the duration of
delivery room breastfeeding did not influence the rate of
hypoglycemia. In contrast to this findings, Chertok et al.
[67] found that breastfed infants had a significantly higher
mean BGL (3.20 mmol/l) compared to those who were
formula fed (2.68 mmol/l). One reason for the different
results could arise from the definition of hypoglycemia.
In Garcia-Patterson et al. [57] hypoglycemia was defined
as “normal” (≥ 2.6 mmol/l), “mild hypoglycemia” (2.2–
2.5 mmol/l), “moderate hypoglycemia” (1.7–2.1 mmol/l)
and “severe hypoglycemia” (1.7 mmol/l). While Chertok
et al. [67] defined hypoglycemia as BGL<1.93 mmol/l
and borderline hypoglycemia was 1.93–2.48 mmol/l. In
addition to differences in measurement, the difference in
adjusting factors may have contributed to the apparent
contrast in the results.
Ramos et al. [15] assessed factors associated with
hypoglycemia in a cohort of pregnancies with T2D and
GDM. The incidence of hypoglycemia in this study was
18% (44/242). The frequency of hypoglycemia between
the glyburide and insulin-treated pregnancies did not differ
significantly (23% vs. 27%). Maternal age ≥ 35 years
(OR: 2.78, 95% CI: 1.13–6.85) and Ponderal Index (OR:
5.59 95% CI: 1.34–23.25), a measure of fetal adiposity,
significantly predicted hypoglycemia. Similarly, Majeed
et al. [44] investigated if maternal glycated hemoglobin
(HbA1c) was a good predictor of hypoglycemia. As
hypothesized HbA1c in late pregnancy, between 36 and 38
weeks of gestation, significantly predicted hypoglycemia
in the newborn, giving an area under the ROC curve
of 0.99 with a 95% CI of 0.992 to 1. A ROC curve
determined the optimal cut-off point for maternal HbA1c
level in predicting hypoglycemia, was 51 mmol/l (6.8%).
Curr Pediatr Res 2017 Volume 21 Issue 1
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Flores-le
Roux et al.
(2012) [27]
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
13/15=86.66

Sarkar et al. Taylor et al. Tundidor et
(2003) [42] (2002) [61] al. (2012) [62]

Yes
Yes
Yes
Yes
No
No
Yes
Yes
Yes
Yes
No
No
No
No
No
No
No
No
Yes
No
Yes
Yes
No
Yes
Yes
Yes
Yes
No
No
Yes
Yes
Yes
Yes
Yes
No
No
Yes
No
No
Yes
No
No
Yes
No
No
12/15=80.00 4/15=26.66 7/15=46.66

Ryan et al.
(2012) [60]

Yes
No
No
Yes
No
No
No
Yes
Yes
No
Yes
No
No
No
No
5/15=33.33

VanHaltren
et al.
(2013)
Yes
No
Yes
No
No
No
No
Yes
Yes
No
No
No
Yes
Yes
No
6/15=40.00

Table 3. Description of methodological quality assessment
GarciaAgrawal et al. Majeed et al. Bollepalli et Ferrara et al.
Das et al. Metzger et al. Mitrovic et al. Persson et al. Ramos et al.
Items
Patterson et
(2000) [22]
(2011) [44] al. (2010) [56] (2007) [55]
(2009) [58] (2014) [35]
(2014) [59]
(2012) [43]
(2010) [15]
al. (2012) [57]
1. Study design
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
2. Setting
Yes
Yes
Yes
Yes
No
No
No
No
No
No
3. Participants
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
4. Variables
Yes
Yes
Yes
Yes
No
No
No
No
Yes
Yes
5. Measurement
Yes
No
No
Yes
Yes
No
Yes
No
No
No
6. Bias
No
No
No
No
No
No
No
No
Yes
No
7. Study size
No
No
No
No
No
No
No
No
Yes
No
8. Statistical methods
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
9. Discriptive data
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
10. Outcome data
No
No
No
Yes
No
Yes
No
No
No
No
11. Main results
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
12. Key Result
Yes
Yes
Yes
Yes
Yes
No
No
No
Yes
No
13. Limitations
Yes
Yes
No
Yes
No
Yes
No
No
Yes
No
14. Interpretation
Yes
Yes
Yes
Yes
No
No
No
No
Yes
Yes
15. Generalizability
Yes
No
No
Yes
No
No
No
No
Yes
No
Percentages of Yes (%) 12/15=80.00 10/15=66.66 9/15=60.00 13/15=86.66 7/15=46.66 6/15=40.00 6/16=40.00 4/15=26.66 12/15=80.00 7/15=46.66
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However, various studies gave mixed results regarding the
association between maternal HbA1c and hypoglycemia.
Using logistic regression Kline and Edwards also found
that a third trimester HbA1c of >6.5% (47.54 mmol/l)
had a stronger association with neonatal hypoglycemia
requiring intervention when compared to maternal
delivery BGLs (OR: 3.89, 95% CI: 1.42-10.68). However,
Taylor et al. [62] found that hypoglycemia correlates with
maternal hyperglycemia in labor, not with HbA1c during
pregnancy. They found that maternal blood glucose during
labor influenced neonatal blood glucose if over 8 mmol/l.

Discussion
Neonatal hypoglycemia is the most common metabolic
abnormality in newborn infants due to the inability to
maintain glucose homeostasis [1,12]. To date, the full
extent of various risk factors of hypoglycemia in infants
of diabetic mothers are not known. Our findings are the
result of a systematic search for all relevant studies on
hypoglycemia in diabetic mothers and critical appraisal of
methodologies and study quality assessment.
We found few prospective studies that carefully examined
the clinical and demographic risk factors of hypoglycemia
among neonates. However, the majority of studies identified
in our literature review were observational of retrospective
design that used existing institutional databases. As a
result, after assessing studies’ strengths, weaknesses and
generalizability using the STROBE Statement, the overall
quality of evidence was low [68]. The clinical risk factors
in these studies can be broadly classified into two: infantrelated and mother-related clinical risk factors. The infantrelated significant risk factors identified in these study were
SGA, LGA, macrosomia, prematurity, lower cord blood
glucose, Ponderal Index and male sex [15,35,43,56,58,63].
On the other hand, mother-related significant risk factor
of hypoglycemia includes maternal hyperglycemia, ethnic
origin, diabetes diagnosed prior to 28 weeks of gestation,
pre-pregnancy BMI ≥ 25 kg/m2, hyperglycemia, blood
glucose, maternal diabetes type and material HbA1c
[22,27,44,57,61,63]. Although several other risk factors
were considered in these studies, the statistically significant
risk factors are important for understanding the clinical
management of the study population and future studies
using multilevel design of risk assessment. Irrespective of
diabetes type, it appears that infants of diabetic mothers
have a higher risk of hypoglycemia compared to those
born to normal mothers [42,55].
Overall, the results of the individual studies assessed
various risk factors. However, a consistent pattern of risks
of hypoglycemia among infants of diabetic mothers was not
identified which may be the result of several factors. First,
as the definition of clinical significance of hypoglycemia
remains one of the contentious issues in contemporary
neonatology, individual studies included in this review
used different definitions of hypoglycemia ranging from
<1.1 mmol/l to <2.8 mmol/l. The variation in the definition
of hypoglycemia has an important implication on the
predictive power of individual studies. The standard of
care in most neonatology units involves close surveillance
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if the plasma glucose concentration is less than 2.2 mmol/l
[69-77]. Second, mothers included in this review were
diagnosed with diabetes. However, there was variation
in the type of diabetes. The review included mothers
with T1D, T2D, GDM, which are commonly recognized
[49,50]. Sarkar et al. [42] pointed out that the incidence
of hypoglycemia and the associated risk factors may vary
based on the specific type of diabetes. Third, about 65% of
studies identified in the review were observational studies
that used existing data collected as part of standard of care
(i.e., not for research purpose). In this regard, collecting
prospective data or using national registry data may have
provided more consistent predictors of hypoglycemia.
Fourth, individual studies used different measurements
of blood glucose. Although, more than 76% of studies
specified their blood glucose measurement methods,
variations in these methods, measurement time, and place
(laboratory vs. bedside) may have affected the accuracy of
blood glucose measurement. Similarly, a recent systematic
review identified 18 studies that examined neonatal
hypoglycemia and its relationship to neurodevelopmental
outcomes found a higher rate of heterogeneity among
studies [78]. In our study, we also found major clinical
heterogeneity in patient characteristics, measurement of
hypoglycemia, design, and quality. As a result, statistical
pooling of result to conduct a meta-analysis was not
carried out.
Overall, the majority of the studies in our review were
observational in design, which makes an inference of
causality difficult, especially when different protocols were
followed to measure, handle and analyze blood sampling.
Less than a third of the studies used a prospective design
to minimize errors associated with measuring exposure.
Key limitations include the possibility of publication bias.
As our review found both positive and negative results,
publication bias may not be a great concern for the current
review. The fact that our systematic review included
studies only written in English may be another limitation.
However, previous studies have shown that language
restrictions in systematic reviews have minimal effect
on the results [79,80]. The fact that 47 percent of studies
did not report a laboratory measurement for confirmation
of neonatal hypoglycemia and the lack of generally
acceptable definition of neonatal hypoglycemia may have
affected the proper dictation of the outcome. However,
as all studies followed a written clinical protocol in the
management of hypoglycemia, the bias associated with
laboratory confirmation is not differential.

Conclusion and Recommendations for Future
Research
In summary, there is evidence supporting the clinical
importance of giving attention to infants of diabetic
mothers. Irrespective of the type of diabetes, infants
of diabetic mothers have a higher risk of developing
hypoglycemia compared to those born to mothers
without diabetes. However, the studies included in this
review mainly focused on the clinical characteristics
of the infants and mothers. Future research should also
Curr Pediatr Res 2017 Volume 21 Issue 1
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focus on identifying other factors that may increase the
risk of neonatal hypoglycemia such as neighborhood
and institutional characteristics including, genetics,
socioeconomic status, and disparities in health care
delivery. This can be accomplished by taking the following
three steps:
1. Defining neonatal hypoglycemia using the multiple
clinical cut-of-points to identify the most salient
risk factors.
2. Using large population based national registry
database that is developed to facilitate the conduct
of analyses pertaining to neonatal complications
will help to obtain adequate comparison groups.
Most of the studies included in this review used
hospital based data that is generated as part of
standard of care.
3. Stratifying the mother’s diabetes type to identify
the significance of T1D, T2D and GDM on the risk
of developing neonatal hypoglycemia.
4. Using multilevel statistical models to incorporate
the individual and contextual characteristics of
infants and mothers.
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